GWAS data have also implicated PROCR variants in myocardial infarction, deep vein thrombosis, and pregnancy-associated thrombosis, supporting the notion that genetic alterations in EPCR can modulate thrombotic risk. Here, PROCR is linked to Venous thrombosis.